177 related articles for article (PubMed ID: 27105158)
21. Immunosuppression with an interleukin-2 fusion protein leads to improved LV function in experimental ischemic cardiomyopathy.
Koch M; Savvatis K; Scheeler M; Dhayat S; Bonaventura K; Pohl T; Riad A; Bulfone-Paus S; Schultheiss HP; Tschöpe C
Int Immunopharmacol; 2010 Feb; 10(2):207-12. PubMed ID: 19897056
[TBL] [Abstract][Full Text] [Related]
22. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
23. Activation of Foxo1 by insulin resistance promotes cardiac dysfunction and β-myosin heavy chain gene expression.
Qi Y; Zhu Q; Zhang K; Thomas C; Wu Y; Kumar R; Baker KM; Xu Z; Chen S; Guo S
Circ Heart Fail; 2015 Jan; 8(1):198-208. PubMed ID: 25477432
[TBL] [Abstract][Full Text] [Related]
24. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
[TBL] [Abstract][Full Text] [Related]
25. Myocardial Upregulation of Cathepsin D by Ischemic Heart Disease Promotes Autophagic Flux and Protects Against Cardiac Remodeling and Heart Failure.
Wu P; Yuan X; Li F; Zhang J; Zhu W; Wei M; Li J; Wang X
Circ Heart Fail; 2017 Jul; 10(7):. PubMed ID: 28694354
[TBL] [Abstract][Full Text] [Related]
26. Wild-type p53-induced Phosphatase 1 Deficiency Exacerbates Myocardial Infarction-induced Ischemic Injury.
Liu KM; Zhang HH; Wang YN; Wang LM; Chen HY; Long CF; Zhang LF; Zhang HB; Yan HB
Chin Med J (Engl); 2017 Jun; 130(11):1333-1341. PubMed ID: 28524834
[TBL] [Abstract][Full Text] [Related]
27. MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction.
van Rooij E; Doevendans PA; Crijns HJ; Heeneman S; Lips DJ; van Bilsen M; Williams RS; Olson EN; Bassel-Duby R; Rothermel BA; De Windt LJ
Circ Res; 2004 Feb; 94(3):e18-26. PubMed ID: 14739160
[TBL] [Abstract][Full Text] [Related]
28. Effects of levosimendan on cardiac gene expression profile and post-infarct cardiac remodelling in diabetic Goto-Kakizaki rats.
Vahtola E; Storvik M; Louhelainen M; Merasto S; Lakkisto P; Lakkisto J; Tikkanen I; Kaheinen P; Levijoki J; Mervaala E
Basic Clin Pharmacol Toxicol; 2011 Nov; 109(5):387-97. PubMed ID: 21699655
[TBL] [Abstract][Full Text] [Related]
29. Transplantation of Epigenetically Modified Adult Cardiac c-Kit+ Cells Retards Remodeling and Improves Cardiac Function in Ischemic Heart Failure Model.
Zakharova L; Nural-Guvener H; Feehery L; Popovic-Sljukic S; Gaballa MA
Stem Cells Transl Med; 2015 Sep; 4(9):1086-96. PubMed ID: 26240433
[TBL] [Abstract][Full Text] [Related]
30. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
31. [Adenoviral short hairpin RNA targeting phosphodiesterase 5 attenuates cardiac remodeling and cardiac dysfunction following myocardial infarction in mice].
Zhang J; Jin Z; Li L; Gang L; Yu Q; Wang M; Song A; Hong B
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):321-6. PubMed ID: 24924460
[TBL] [Abstract][Full Text] [Related]
32. Cathepsin A inhibition attenuates myocardial infarction-induced heart failure on the functional and proteomic levels.
Petrera A; Gassenhuber J; Ruf S; Gunasekaran D; Esser J; Shahinian JH; Hübschle T; Rütten H; Sadowski T; Schilling O
J Transl Med; 2016 May; 14(1):153. PubMed ID: 27246731
[TBL] [Abstract][Full Text] [Related]
33. Critical role for leukocyte hypoxia inducible factor-1alpha expression in post-myocardial infarction left ventricular remodeling.
Dong F; Khalil M; Kiedrowski M; O'Connor C; Petrovic E; Zhou X; Penn MS
Circ Res; 2010 Feb; 106(3):601-10. PubMed ID: 20035082
[TBL] [Abstract][Full Text] [Related]
34. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
Adamek A; Hu K; Bayer B; Wagner H; Ertl G; Bauersachs J; Frantz S
Basic Res Cardiol; 2007 Jul; 102(4):334-40. PubMed ID: 17340057
[TBL] [Abstract][Full Text] [Related]
35. SIRT1 protects against myocardial ischemia-reperfusion injury via activating eNOS in diabetic rats.
Ding M; Lei J; Han H; Li W; Qu Y; Fu E; Fu F; Wang X
Cardiovasc Diabetol; 2015 Oct; 14():143. PubMed ID: 26489513
[TBL] [Abstract][Full Text] [Related]
36. CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice.
Montecucco F; Braunersreuther V; Lenglet S; Delattre BM; Pelli G; Buatois V; Guilhot F; Galan K; Vuilleumier N; Ferlin W; Fischer N; Vallée JP; Kosco-Vilbois M; Mach F
Eur Heart J; 2012 Aug; 33(15):1964-74. PubMed ID: 21606075
[TBL] [Abstract][Full Text] [Related]
37. Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction.
Xiao J; Moon M; Yan L; Nian M; Zhang Y; Liu C; Lu J; Guan H; Chen M; Jiang D; Jiang H; Liu PP; Li H
Basic Res Cardiol; 2012 Jan; 107(1):239. PubMed ID: 22202974
[TBL] [Abstract][Full Text] [Related]
38. Biglycan is required for adaptive remodeling after myocardial infarction.
Westermann D; Mersmann J; Melchior A; Freudenberger T; Petrik C; Schaefer L; Lüllmann-Rauch R; Lettau O; Jacoby C; Schrader J; Brand-Herrmann SM; Young MF; Schultheiss HP; Levkau B; Baba HA; Unger T; Zacharowski K; Tschöpe C; Fischer JW
Circulation; 2008 Mar; 117(10):1269-76. PubMed ID: 18299507
[TBL] [Abstract][Full Text] [Related]
39. Expression of bone morphogenetic protein 4 and its receptors in the remodeling heart.
Wu X; Sagave J; Rutkovskiy A; Haugen F; Baysa A; Nygård S; Czibik G; Dahl CP; Gullestad L; Vaage J; Valen G
Life Sci; 2014 Mar; 97(2):145-54. PubMed ID: 24398041
[TBL] [Abstract][Full Text] [Related]
40. HMGB1: the missing link between diabetes mellitus and heart failure.
Volz HC; Seidel C; Laohachewin D; Kaya Z; Müller OJ; Pleger ST; Lasitschka F; Bianchi ME; Remppis A; Bierhaus A; Katus HA; Andrassy M
Basic Res Cardiol; 2010 Nov; 105(6):805-20. PubMed ID: 20703492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
